NCT07502495: Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
- State
- Under way
- Phase
- Phase 2
- People
- 64 taking part
- Started
- 27 Mar 2026
- Primary completion
- Mar 2027
- Arms
- Arm A: icovamenib 100 mg
- Results
- None posted
- 27 Mar 2026: Trial started
- 31 Mar 2026: Trial registered